206 related articles for article (PubMed ID: 27161874)
1. Synthesis and bioevaluation of substituted chalcones, coumaranones and other flavonoids as anti-HIV agents.
Cole AL; Hossain S; Cole AM; Phanstiel O
Bioorg Med Chem; 2016 Jun; 24(12):2768-76. PubMed ID: 27161874
[TBL] [Abstract][Full Text] [Related]
2. Anti-HIV and antiplasmodial activity of original flavonoid derivatives.
Casano G; Dumètre A; Pannecouque C; Hutter S; Azas N; Robin M
Bioorg Med Chem; 2010 Aug; 18(16):6012-23. PubMed ID: 20638854
[TBL] [Abstract][Full Text] [Related]
3. Anti-HIV cytotoxicity enzyme inhibition and molecular docking studies of quinoline based chalcones as potential non-nucleoside reverse transcriptase inhibitors (NNRT).
Hameed A; Abdullah MI; Ahmed E; Sharif A; Irfan A; Masood S
Bioorg Chem; 2016 Apr; 65():175-82. PubMed ID: 26964017
[TBL] [Abstract][Full Text] [Related]
4. Anti-AIDS agents 54. A potent anti-HIV chalcone and flavonoids from genus Desmos.
Wu JH; Wang XH; Yi YH; Lee KH
Bioorg Med Chem Lett; 2003 May; 13(10):1813-5. PubMed ID: 12729671
[TBL] [Abstract][Full Text] [Related]
5. Functional evaluation of synthetic flavonoids and chalcones for potential antiviral and anticancer properties.
Mateeva N; Eyunni SVK; Redda KK; Ononuju U; Hansberry TD; Aikens C; Nag A
Bioorg Med Chem Lett; 2017 Jun; 27(11):2350-2356. PubMed ID: 28442256
[TBL] [Abstract][Full Text] [Related]
6. Ferrocenyl chalcone difluoridoborates inhibit HIV-1 integrase and display low activity towards cancer and endothelial cells.
Monserrat JP; Al-Safi RI; Tiwari KN; Quentin L; Chabot GG; Vessières A; Jaouen G; Neamati N; Hillard EA
Bioorg Med Chem Lett; 2011 Oct; 21(20):6195-7. PubMed ID: 21889342
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis and Docking Studies of Flavokawain B Type Chalcones and Their Cytotoxic Effects on MCF-7 and MDA-MB-231 Cell Lines.
Abu Bakar A; Akhtar MN; Mohd Ali N; Yeap SK; Quah CK; Loh WS; Alitheen NB; Zareen S; Ul-Haq Z; Shah SAA
Molecules; 2018 Mar; 23(3):. PubMed ID: 29518053
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of prostaglandin E(2) production by synthetic minor prenylated chalcones and flavonoids: synthesis, biological activity, crystal structure, and in silico evaluation.
Rullah K; Mohd Aluwi MF; Yamin BM; Abdul Bahari MN; Wei LS; Ahmad S; Abas F; Ismail NH; Jantan I; Wai LK
Bioorg Med Chem Lett; 2014 Aug; 24(16):3826-34. PubMed ID: 25027933
[TBL] [Abstract][Full Text] [Related]
9. Influence of the skeleton on the cytotoxicity of flavonoids.
Lewin G; Aubert G; Thoret S; Dubois J; Cresteil T
Bioorg Med Chem; 2012 Feb; 20(3):1231-9. PubMed ID: 22257529
[TBL] [Abstract][Full Text] [Related]
10. Semi-synthesis and NMR spectral assignments of flavonoid and chalcone derivatives.
Kumar R; Lu Y; Elliott AG; Kavanagh AM; Cooper MA; Davis RA
Magn Reson Chem; 2016 Nov; 54(11):880-886. PubMed ID: 27379746
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Biological Evaluation, and Molecular Simulation of Chalcones and Aurones as Selective MAO-B Inhibitors.
Morales-Camilo N; Salas CO; Sanhueza C; Espinosa-Bustos C; Sepúlveda-Boza S; Reyes-Parada M; Gonzalez-Nilo F; Caroli-Rezende M; Fierro A
Chem Biol Drug Des; 2015 Jun; 85(6):685-95. PubMed ID: 25346162
[TBL] [Abstract][Full Text] [Related]
12. Convenient Synthesis and Physiological Activities of Flavonoids in Coreopsis lanceolata L. Petals and Their Related Compounds.
Nakabo D; Okano Y; Kandori N; Satahira T; Kataoka N; Akamatsu J; Okada Y
Molecules; 2018 Jul; 23(7):. PubMed ID: 29987259
[TBL] [Abstract][Full Text] [Related]
13. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
14. Antiplasmodial dimeric chalcone derivatives from the roots of Uvaria siamensis.
Salae AW; Chairerk O; Sukkoet P; Chairat T; Prawat U; Tuntiwachwuttikul P; Chalermglin P; Ruchirawat S
Phytochemistry; 2017 Mar; 135():135-143. PubMed ID: 27989370
[TBL] [Abstract][Full Text] [Related]
15. Chalcones and flavonoids as anti-tuberculosis agents.
Lin YM; Zhou Y; Flavin MT; Zhou LM; Nie W; Chen FC
Bioorg Med Chem; 2002 Aug; 10(8):2795-802. PubMed ID: 12057669
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activities of flavonoids: structure-activity relationship and mechanism.
Xie Y; Yang W; Tang F; Chen X; Ren L
Curr Med Chem; 2015; 22(1):132-49. PubMed ID: 25245513
[TBL] [Abstract][Full Text] [Related]
17. Natural and synthetic 2'-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity.
Detsi A; Majdalani M; Kontogiorgis CA; Hadjipavlou-Litina D; Kefalas P
Bioorg Med Chem; 2009 Dec; 17(23):8073-85. PubMed ID: 19853459
[TBL] [Abstract][Full Text] [Related]
18. Flavonol and chalcone ester glycosides from Bidens leucantha.
De Tommasi N; Pizza C; Aquino R; Cumandà J; Mahmood N
J Nat Prod; 1997 Mar; 60(3):270-3. PubMed ID: 9090869
[TBL] [Abstract][Full Text] [Related]
19. 5'-Chloro-2,2'-dihydroxychalcone and related flavanoids as treatments for prostate cancer.
Saito Y; Mizokami A; Tsurimoto H; Izumi K; Goto M; Nakagawa-Goto K
Eur J Med Chem; 2018 Sep; 157():1143-1152. PubMed ID: 30189396
[TBL] [Abstract][Full Text] [Related]
20. The scope of thallium nitrate oxidative cyclization of chalcones; synthesis and evaluation of isoflavone and aurone analogs for their inhibitory activity against interleukin-5.
Thanigaimalai P; Yang HM; Sharma VK; Kim Y; Jung SH
Bioorg Med Chem; 2010 Jun; 18(12):4441-5. PubMed ID: 20472438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
